Microtesla magnetic therapy
Intervention1 paper3 findings
- Human trial1
Outcomes
3Organismal OrganAge
downin humans1Moderate certainty
1 study
Organismal OrganAge
downin humans1Moderate certainty
Microtesla magnetic therapy decreases Organismal OrganAge in humans.
Human trialin Long COVID patients responding to MMTplasma4 weeks
Plasma Proteomics Identifies a Microtesla Magnetic Therapy Response Signature in Long COVID · medRxiv · 27 Aug 2026 · Preprint
Brain OrganAge
downin humans1Moderate certainty
1 study
Brain OrganAge
downin humans1Moderate certainty
Microtesla magnetic therapy decreases Brain OrganAge in humans.
Human trialin Long COVID patients responding to MMTplasma4 weeks
Plasma Proteomics Identifies a Microtesla Magnetic Therapy Response Signature in Long COVID · medRxiv · 27 Aug 2026 · Preprint
Clinical improvement
upin humans1Moderate certainty
1 study
Clinical improvement
upin humans1Moderate certainty
Microtesla magnetic therapy improves clinical improvement in humans.
Human trialin Long COVID patientslow amplitude radiofrequency electromagnetic field intervention delivered to the whole brainbrain4 weeks
Plasma Proteomics Identifies a Microtesla Magnetic Therapy Response Signature in Long COVID · medRxiv · 27 Aug 2026 · Preprint